Low Fluorodeoxyglucose Uptake in the Metastatic Lung Tumor From Clear Cell Renal Cell Carcinoma

被引:0
作者
Yoshida, Mami [1 ]
Oura, Shoji [1 ]
机构
[1] Kishiwada Tokushukai Hosp, Surg, Kishiwada, Japan
关键词
metastatic lung tumor; low suv max; lipid; glycogen; clear cell renal cell carcinoma; CANCER; PET;
D O I
10.7759/cureus.67854
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 78-year-old man had undergone laparoscopic left nephrectomy for clear cell renal cell carcinoma (CCRCC) and, three years later, partial resection for a lung metastasis of CCRCC. Follow-up computed tomography (CT) again showed a solitary oval lung nodule that was adjacent to the pulmonary vein, leading to careful CT follow-up without trans-bronchial lung biopsy. The lung nodule grew rapidly from 18 mm to 25 mm in a year. However, positron emission tomography showed only a slight increase in the maximal standardized uptake value (SUV max) of 3.76 g/mL. Under the tentative diagnosis of a metastatic lung tumor from CCRCC, the patient underwent lung wedge resection for the presumed lung metastasis. A postoperative pathological study showed a well-circumscribed oval tumor consisting of atypical cells with clear cytoplasm and densely growing in an expansive manner. Immunostaining using paraffin-embedded tissue showed that lipid droplets were observed on the tumor cells and periodic-acid Schiff (PAS)-positive granules were confirmed in the cytoplasm of the atypical cells. Oncologists should note that the SUV max value of metastatic lung tumors from CCRCC is ostensibly low due to the presence of intracytoplasmic lipids and glycogen.
引用
收藏
页数:5
相关论文
共 11 条
  • [1] Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study
    Bul, Meelan
    Zhu, Xiaoye
    Valdagni, Riccardo
    Pickles, Tom
    Kakehi, Yoshiyuki
    Rannikko, Antti
    Bjartell, Anders
    van der Schoot, Deric K.
    Cornel, Erik B.
    Conti, Giario N.
    Boeve, Egbert R.
    Staerman, Frederic
    Vis-Maters, Jenneke J.
    Vergunst, Henk
    Jaspars, Joris J.
    Stroelin, Petra
    van Muilekom, Erik
    Schroder, Fritz H.
    Bangma, Chris H.
    Roobol, Monique J.
    [J]. EUROPEAN UROLOGY, 2013, 63 (04) : 597 - 603
  • [2] Accuracy of FDG-PET to Diagnose Lung Cancer in Areas With Infectious Lung Disease A Meta-analysis
    Deppen, Stephen A.
    Blume, Jeffrey D.
    Kensinger, Clark D.
    Morgan, Ashley M.
    Aldrich, Melinda C.
    Massion, Pierre P.
    Walker, Ronald C.
    McPheeters, Melissa L.
    Putnam, Joe B., Jr.
    Grogan, Eric L.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (12): : 1227 - 1236
  • [3] 18F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review
    Dondi, Francesco
    Albano, Domenico
    Giubbini, Raffaele
    Bertagna, Francesco
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (12) : 1293 - 1300
  • [4] Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer - A meta-analysis
    Gould, MK
    Kuschner, WG
    Rydzak, CE
    Maclean, CC
    Demas, AN
    Shigemitsu, H
    Chan, JK
    Owens, DK
    [J]. ANNALS OF INTERNAL MEDICINE, 2003, 139 (11) : 879 - 892
  • [5] Expert Consensus Document on Pulmonary Metastasectomy
    Handy, John R.
    Bremner, Ross M.
    Crocenzi, Todd S.
    Detterbeck, Frank C.
    Fernando, Hiran C.
    Fidias, Panos M.
    Firestone, Scott
    Johnstone, Candice A.
    Lanuti, Michael
    Litle, Virginia R.
    Kesler, Kenneth A.
    Mitchell, John D.
    Pass, Harvey I.
    Ross, Helen J.
    Varghese, Thomas K.
    [J]. ANNALS OF THORACIC SURGERY, 2019, 107 (02) : 631 - 649
  • [6] Pulmonary metastasectomy: outcomes and issues according to the type of surgical resection
    Higashiyama M.
    Tokunaga T.
    Nakagiri T.
    Ishida D.
    Kuno H.
    Okami J.
    [J]. General Thoracic and Cardiovascular Surgery, 2015, 63 (6) : 320 - 330
  • [7] Kondo Haruhiko, 2005, Int J Clin Oncol, V10, P81
  • [8] DESCRIPTIVE ANALYSIS OF OLIGOMETASTATIC LESIONS TREATED WITH CURATIVE-INTENT STEREOTACTIC BODY RADIOTHERAPY
    Milano, Michael T.
    Katz, Alan W.
    Schell, Michael C.
    Philip, Abraham
    Okunieff, Paul
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (05): : 1516 - 1522
  • [9] Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases
    Pastorino, U
    Buyse, M
    Friedel, G
    Ginsberg, RJ
    Girard, P
    Goldstraw, P
    Johnston, M
    McCormack, P
    Pass, H
    Putnam, JB
    Cerrina, J
    Chapelier, A
    Dartevelle, P
    Baldeyrou, P
    Grunenwald, D
    Bulzebruck, H
    Schirren, J
    VogtMoykopf, I
    Toomes, H
    vanGeel, AN
    Cappello, M
    Rocmans, P
    Pietraszek, A
    Sklodowska, M
    Andreani, S
    Incarbone, M
    Ravasi, G
    Tavecchio, L
    Ambrogi, V
    Ricci, C
    Mineo, T
    Maggi, G
    Briccoli, A
    Gelmini, R
    Heidari, A
    Guernelli, N
    Beltrami, V
    Bains, MS
    Burt, ME
    Martini, N
    McCormack, PM
    Rusch, VW
    Roth, J
    Holmes, C
    Temeck, B
    Marchand, P
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1997, 113 (01) : 37 - 47
  • [10] Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
    Rusthoven, Kyle E.
    Kavanagh, Brian D.
    Burri, Stuart H.
    Chen, Changhu
    Cardenes, Higinia
    Chidel, Mark A.
    Pugh, Thomas J.
    Kane, Madeleine
    Gaspar, Laurie E.
    Schefter, Tracey E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (10) : 1579 - 1584